Fig. 3From: circCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblastscircCRAMP1L expression in circulating plasma of patients with preeclampsia compared to normal pregnant women (2.66 ± 0.82 vs. 3.95 ± 0.67, P = 0.001)Back to article page